227 related articles for article (PubMed ID: 8794703)
1. Eye manifestations of congenital toxoplasmosis.
Mets MB; Holfels E; Boyer KM; Swisher CN; Roizen N; Stein L; Stein M; Hopkins J; Withers S; Mack D; Luciano R; Patel D; Remington JS; Meier P; McLeod R
Am J Ophthalmol; 1996 Sep; 122(3):309-24. PubMed ID: 8794703
[TBL] [Abstract][Full Text] [Related]
2. Eye manifestations of congenital toxoplasmosis.
Mets MB; Holfels E; Boyer KM; Swisher CN; Roizen N; Stein L; Stein M; Hopkins J; Withers S; Mack D; Luciano R; Patel D; Remington JS; Meier P; McLeod R
Am J Ophthalmol; 1997 Jan; 123(1):1-16. PubMed ID: 9186091
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal study of new eye lesions in treated congenital toxoplasmosis.
Phan L; Kasza K; Jalbrzikowski J; Noble AG; Latkany P; Kuo A; Mieler W; Meyers S; Rabiah P; Boyer K; Swisher C; Mets M; Roizen N; Cezar S; Remington J; Meier P; McLeod R;
Ophthalmology; 2008 Mar; 115(3):553-559.e8. PubMed ID: 17825418
[TBL] [Abstract][Full Text] [Related]
4. Ocular manifestations in congenital toxoplasmosis.
Kodjikian L; Wallon M; Fleury J; Denis P; Binquet C; Peyron F; Garweg JG
Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):14-21. PubMed ID: 15906073
[TBL] [Abstract][Full Text] [Related]
5. Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.
Roizen N; Kasza K; Karrison T; Mets M; Noble AG; Boyer K; Swisher C; Meier P; Remington J; Jalbrzikowski J; McLeod R; Kipp M; Rabiah P; Chamot D; Estes R; Cezar S; Mack D; Pfiffner L; Stein M; Danis B; Patel D; Hopkins J; Holfels E; Stein L; Withers S; Cameron A; Perkins J; Heydemann P
Pediatrics; 2006 Aug; 118(2):e379-90. PubMed ID: 16864640
[TBL] [Abstract][Full Text] [Related]
6. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial.
McAuley J; Boyer KM; Patel D; Mets M; Swisher C; Roizen N; Wolters C; Stein L; Stein M; Schey W
Clin Infect Dis; 1994 Jan; 18(1):38-72. PubMed ID: 8054436
[TBL] [Abstract][Full Text] [Related]
7. Neurologic and developmental outcome in treated congenital toxoplasmosis.
Roizen N; Swisher CN; Stein MA; Hopkins J; Boyer KM; Holfels E; Mets MB; Stein L; Patel D; Meier P
Pediatrics; 1995 Jan; 95(1):11-20. PubMed ID: 7770286
[TBL] [Abstract][Full Text] [Related]
8. Long-term ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children.
Faucher B; Garcia-Meric P; Franck J; Minodier P; Francois P; Gonnet S; L'ollivier C; Piarroux R
J Infect; 2012 Jan; 64(1):104-9. PubMed ID: 22051915
[TBL] [Abstract][Full Text] [Related]
9. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
McLeod R; Boyer K; Karrison T; Kasza K; Swisher C; Roizen N; Jalbrzikowski J; Remington J; Heydemann P; Noble AG; Mets M; Holfels E; Withers S; Latkany P; Meier P;
Clin Infect Dis; 2006 May; 42(10):1383-94. PubMed ID: 16619149
[TBL] [Abstract][Full Text] [Related]
10. [Ocular toxoplasmosis: our experience].
Russo M; Pergola G; Pedicini G
Infez Med; 2005 Sep; 13(3):160-7. PubMed ID: 16397419
[TBL] [Abstract][Full Text] [Related]
11. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis.
Bosch-Driessen LH; Verbraak FD; Suttorp-Schulten MS; van Ruyven RL; Klok AM; Hoyng CB; Rothova A
Am J Ophthalmol; 2002 Jul; 134(1):34-40. PubMed ID: 12095805
[TBL] [Abstract][Full Text] [Related]
12. Ocular toxoplasmosis: clinical features and prognosis of 154 patients.
Bosch-Driessen LE; Berendschot TT; Ongkosuwito JV; Rothova A
Ophthalmology; 2002 May; 109(5):869-78. PubMed ID: 11986090
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
[TBL] [Abstract][Full Text] [Related]
14. Long-term ocular prognosis in 327 children with congenital toxoplasmosis.
Wallon M; Kodjikian L; Binquet C; Garweg J; Fleury J; Quantin C; Peyron F
Pediatrics; 2004 Jun; 113(6):1567-72. PubMed ID: 15173475
[TBL] [Abstract][Full Text] [Related]
15. Imaging of congenital toxoplasmosis macular scars with optical coherence tomography.
Garg S; Mets MB; Bearelly S; Mets R
Retina; 2009 May; 29(5):631-7. PubMed ID: 19262439
[TBL] [Abstract][Full Text] [Related]
16. Ophthalmic outcomes after prenatal and postnatal treatment of congenital toxoplasmosis.
Brézin AP; Thulliez P; Couvreur J; Nobré R; Mcleod R; Mets MB
Am J Ophthalmol; 2003 Jun; 135(6):779-84. PubMed ID: 12788116
[TBL] [Abstract][Full Text] [Related]
17. Visual Outcomes in Presumed Congenital Foveal Toxoplasmosis.
Reynolds MMM; Chisholm SAM; Schroeder R; Lueder GT
Am J Ophthalmol; 2020 Jun; 214():9-13. PubMed ID: 32035830
[TBL] [Abstract][Full Text] [Related]
18. Toxoplasmosis transmitted to a newborn from the mother infected 20 years earlier.
Silveira C; Ferreira R; Muccioli C; Nussenblatt R; Belfort R
Am J Ophthalmol; 2003 Aug; 136(2):370-1. PubMed ID: 12888070
[TBL] [Abstract][Full Text] [Related]
19. Ocular Toxoplasmosis in a Tertiary Referral Center in Sydney Australia-Clinical Features, Treatment, and Prognosis.
Yates WB; Chiong F; Zagora S; Post JJ; Wakefield D; McCluskey P
Asia Pac J Ophthalmol (Phila); 2019; 8(4):280-284. PubMed ID: 31369405
[TBL] [Abstract][Full Text] [Related]
20. The ocular manifestations of congenital infection: a study of the early effect and long-term outcome of maternally transmitted rubella and toxoplasmosis.
O'Neill JF
Trans Am Ophthalmol Soc; 1998; 96():813-79. PubMed ID: 10360309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
